Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in pre-clinical models of prostate cancer.

Pamela Maxwell; David Waugh; Melissa LaBonte Wilson

Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in pre-clinical models of prostate cancer.

Pamela Maxwell, David Waugh, Melissa LaBonte Wilson^*

^*Corresponding author for this work

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Published - 05 Dec 2017
Event	AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research - Disney's Boardwalk Inn, Orlando, United States Duration: 02 Dec 2017 → 05 Dec 2017 http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=114#.WkzvF7acajg

Conference

Conference	AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research
Country/Territory	United States
City	Orlando
Period	02/12/2017 → 05/12/2017
Internet address	http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=114#.WkzvF7acajg

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{28778410190a40e28c933c2d60a1eee9,

title = "Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in pre-clinical models of prostate cancer.",

author = "Pamela Maxwell and David Waugh and {LaBonte Wilson}, Melissa",

year = "2017",

month = dec,

day = "5",

language = "English",

note = "AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research ; Conference date: 02-12-2017 Through 05-12-2017",

url = "http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=114#.WkzvF7acajg",

}

Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in pre-clinical models of prostate cancer. / Maxwell, Pamela; Waugh, David; LaBonte Wilson, Melissa.
2017. Abstract from AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research, Orlando, Florida, United States.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in pre-clinical models of prostate cancer.

AU - Maxwell, Pamela

AU - Waugh, David

AU - LaBonte Wilson, Melissa

PY - 2017/12/5

Y1 - 2017/12/5

M3 - Abstract

T2 - AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research

Y2 - 2 December 2017 through 5 December 2017

ER -